Table 2 Neoadjuvant/ Adjuvant Chemotherapy trials
From: Evolution of treatment in gastric cancer- a systematic review
TRIAL / AUTHOR | PURPOSE | RESULT |
|---|---|---|
MAGIC/ Cunningham et al., 2006 | ECF + surgery vs Surgery alone | Improved Overall survival |
MRC ST03 trial/ Cunningham et al., 2017 | ECF + Bevacizumab vs ECF | No benefit |
FLOT 4-AIO/ Al-Batran et al., 2019 | FLOT vs ECF/ECX | Improved Median survival |
ACTS-GC/ Sasako et al., 2011 | Surgery + S1 vs Surgery | Improved Overall survival |
CLASSIC/ Bang et al., 2012 | Surgery + CAPOX vs Surgery | Better DFS |